Thermo Fisher Scientific is acquiring Mesa Biotech for about $450 million in cash, and will pay an additional $100 million in cash after certain milestones are hit.

U.S. industrial conglomerate 3M Co. has partnered with the Massachusetts Institute of Technology to develop a rapid antigen test for COVID-19.

Abbott’s Afinion HbA1c Dx assay was launched as the only rapid point-of-care test cleared by the U.S. Food and Drug Administration to aid healthcare professionals in the diagnosis of diabetes and the assessment of patients’ risk of developing the condition.

Abbott announced the next phase of partnership with the U.S. Department of Defense and researchers from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Network, one of the largest traumatic brain injury efforts of its kind.

Abbott announced today that the U.S. Food and Drug Administration cleared the company’s next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing.

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, announced the ambr 15 automated micro bioreactor system combined with a Nova Biomedical BioProfile FLEX2 automated cell culture analyzer.

Abbott Laboratories and Alere Inc. have come to an accord. Illinois-based Abbott will acquire Alere for an amount less than the initially agreed upon $5.8 billion.

Danaher Corp. said it would buy medical diagnostics company Cepheid in a deal valued at $4 billion that will strengthen its presence in molecular diagnostics.